EUVIMEDEUVIMED entdecken
Crossref

The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension

Emma Sansby, Colin J Driver, Karla Borland, Imogen Schofield, Joanne Michou

Veterinary Anaesthesia and Analgesia · 2025

DOI: 10.1016/j.vaa.2024.11.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Anaesthesia and Analgesia, 2025. Verfasst von Emma Sansby und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lumbry Park Veterinary Specialists, Alton, Hampshire, UK. Electronic address: emma.sansby@cvsvets.com. Hauptthemen laut MEDLINE: Butorphanol, Dog Diseases, Intracranial Hypertension, Hypnotics and Sedatives. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To determine whether dogs with magnetic resonance imaging (MRI)-determined intracranial space occupying lesions (MRI-iSOLs) or intracranial hypertension (MRI-ICH) had greater sedation scores and quicker onset of recumbency following premedication with intravenous (IV) butorphanol in comparison with dogs which had normal MRI findings. STUDY DESIGN: Prospective, observational study. ANIMALS: A total of 53 dogs presenting for brain MRI were included. METHODS: Each dog was sedated with 0.2 mg kg-1 butorphanol IV, and the quality of sedation and the onset of recumbency were scored before drug administration and every 5 minutes after IV butorphanol administration for 15 minutes using a modified sedation scale. The maximum sedation score was 18, and onset of recumbency was recorded when a dog lay down without the ability to stand. Each MRI was assessed for the presence or absence of MRI-iSOL and MRI-ICH using T2-weighted sequences. Data were analysed using the Wilcoxon rank sum test or the chi-square test. RESULTS: Dogs with MRI-iSOL had significantly higher median sedation scores than dogs without MRI-iSOL (12 versus 5, respectively) 15 minutes after butorphanol administration (T15, p 10 within 15 minutes of butorphanol administration, the animal should be treated with an anaesthesia protocol adapted to the presence of ICH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButorphanolDog DiseasesIntracranial HypertensionHypnotics and SedativesAnimalsDogsMaleFemaleProspective StudiesMagnetic Resonance Imaging

Stichwörter der Autor:innen

anaesthesiabutorphanoldogsintracranial hypertensionmagnetic resonance imagingpremedication

Substanzen

ButorphanolHypnotics and Sedatives

Autor:innen und Institutionen

  • Lumbry Park Veterinary Specialists, Alton, Hampshire, UK. Electronic address: emma.sansby@cvsvets.com.
  • Lumbry Park Veterinary Specialists, Alton, Hampshire, UK.
  • CVS UK Ltd, Diss, Norfolk, UK.

Zitieren

APA

Sansby, E., Driver, C. J., Borland, K., Schofield, I., & Michou, J. (2025). The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension. Veterinary Anaesthesia and Analgesia. https://doi.org/10.1016/j.vaa.2024.11.006

Vancouver

Sansby E, Driver CJ, Borland K, Schofield I, Michou J. The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension. Veterinary Anaesthesia and Analgesia. 2025. doi:10.1016/j.vaa.2024.11.006

BibTeX
@article{Sansby2025,
  author = {Sansby, Emma and Driver, Colin J and Borland, Karla and Schofield, Imogen and Michou, Joanne},
  title = {The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension},
  journal = {Veterinary Anaesthesia and Analgesia},
  year = {2025},
  doi = {10.1016/j.vaa.2024.11.006}
}
Kostenlos starten →